• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX COLONIC; STENT, COLONIC, METALIC, EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX COLONIC; STENT, COLONIC, METALIC, EXPANDABLE Back to Search Results
Model Number M00565060
Device Problems Positioning Failure (1158); Use of Device Problem (1670); Detachment of Device or Device Component (2907)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/18/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported to boston scientific corporation on (b)(6), 2022, that a wallflex enteral colonic stent was to be implanted in the digestive tract to treat a malignant stricture and gastrointestinal bleeding during a stent placement procedure performed on (b)(6), 2022.The patient's anatomy was tortuous and was dilated prior to stent placement.During the procedure, the stent was unable to deploy.When the delivery system was removed, the inner sheath got detached and was removed with forceps.The procedure was completed with another wallflex enteral stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: it was reported that the wallflex enteral colonic stent was to be implanted to treat a gastrointestinal bleeding.Per the wallflex colonic stent system with anchor lock delivery system directions for use (dfu), "the device is indicated for the palliative treatment of colonic strictures produced by malignant neoplasms and to relieve large bowel obstruction prior to colectomy in patients with malignant strictures".The stent is not indicated for the treatment of gastrointestinal bleeding.
 
Manufacturer Narrative
Block b5 has been updated with additional information received on november 16, 2022 and november 25, 2022.Block h6: imdrf device code a0501 captures the reportable event of inner sheath detached.Block h10: a wallflex enteral colonic stent was received for analysis; the delivery system was not returned.The stent was received fully expanded and fully deployed.The stent was inspected and no problems were noted.The reported events of stent failure to deploy and inner shaft/sheath detachment of device or device component could not be confirmed as only the stent was received completely deployed and in good condition.A labeling review was performed, and from the information available, this device was used in a manner inconsistent with the ifu (instructions for use) / product label.The complainant reported that the wallflex enteral colonic stent was to be implanted to treat a gastrointestinal bleeding.The wallflex colonic stent system with anchor lock delivery system instructions for use (ifu) states "the device is indicated for the palliative treatment of colonic strictures produced by malignant neoplasms and to relieve large bowel obstruction prior to colectomy in patients with malignant strictures".However, there is no indication of what the customer reported because the delivery system was not returned and the stent was completely deployed.Therefore, a review and analysis of all available information indicated the most probable cause is no problem detected.
 
Event Description
It was reported to boston scientific corporation on september 20, 2022, that a wallflex enteral colonic stent was to be implanted in the digestive tract to treat a malignant stricture and gastrointestinal bleeding during a stent placement procedure performed on (b)(6) 2022.The patient's anatomy was tortuous and was dilated prior to stent placement.During the procedure, the stent was unable to deploy.When the delivery system was removed, the inner sheath got detached and was removed with forceps.The procedure was completed with another wallflex enteral stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: it was reported that the wallflex enteral colonic stent was to be implanted to treat a gastrointestinal bleeding.Per the wallflex colonic stent system with anchor lock delivery system directions for use (dfu), "the device is indicated for the palliative treatment of colonic strictures produced by malignant neoplasms and to relieve large bowel obstruction prior to colectomy in patients with malignant strictures".The stent is not indicated for the treatment of gastrointestinal bleeding.Additional information received on november 16, 2022 and november 25, 2022: prior to the procedure, the patient was not actively bleeding.The removal of the detached inner sheath did not also contribute to the bleeding.The source of the bleeding was from the ulcers in the intestine.Furthermore, the stent was placed at the site of the malignant stricture; however, the bleeding was not at the site of malignancy.
 
Event Description
It was reported to boston scientific corporation on september 20, 2022, that a wallflex enteral colonic stent was to be implanted in the digestive tract to treat a malignant stricture and gastrointestinal bleeding during a stent placement procedure performed on (b)(6), 2022.The patient's anatomy was tortuous and was dilated prior to stent placement.During the procedure, the stent was unable to deploy.When the delivery system was removed, the inner sheath got detached and was removed with forceps.The procedure was completed with another wallflex enteral stent.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: it was reported that the wallflex enteral colonic stent was to be implanted to treat a gastrointestinal bleeding.Per the wallflex colonic stent system with anchor lock delivery system directions for use (dfu), "the device is indicated for the palliative treatment of colonic strictures produced by malignant neoplasms and to relieve large bowel obstruction prior to colectomy in patients with malignant strictures".The stent is not indicated for the treatment of gastrointestinal bleeding.Additional information received on november 16, 2022 and november 25, 2022.Prior to the procedure, the patient was not actively bleeding.The removal of the detached inner sheath did not also contribute to the bleeding.The source of the bleeding was from the ulcers in the intestine.Furthermore, the stent was placed at the site of the malignant stricture; however, the bleeding was not at the site of malignancy.Update based on medical safety review on december 15, 2022.The stent was intended to treat a malignant stricture; however, since the gastrointestinal bleeding was not noted prior to procedure nor was the bleeding at the site of stent placement, the stent was not used to treat a gastrointestinal bleed.
 
Manufacturer Narrative
Block h6: imdrf device code a0501 captures the reportable event of inner sheath detached.Block h10: a wallflex enteral colonic stent was received for analysis; the delivery system was not returned.The stent was received fully expanded and fully deployed.The stent was inspected and no problems were noted.Product analysis could not confirm the reported events of stent failure to deploy and inner shaft/sheath detachment of device or device component.There is no indication of what the customer reported because the delivery system was not returned, only the fully deployed stent.Therefore, a review and analysis of all available information indicated the most probable cause is no problem detected.A product labeling review identified that the device was used per the instructions for use (ifu) / product label.Block h11: blocks b5, h6 (device codes), and h10 (device analysis) have been corrected based on the review of the complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX COLONIC
Type of Device
STENT, COLONIC, METALIC, EXPANDABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15587478
MDR Text Key301570365
Report Number3005099803-2022-05982
Device Sequence Number1
Product Code MQR
UDI-Device Identifier08714729456537
UDI-Public08714729456537
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K061877
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2023
Device Model NumberM00565060
Device Catalogue Number6506
Device Lot Number0027936221
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/15/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/31/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient SexMale
Patient Weight60 KG
-
-